DelveInsight's Platinum-Resistant Ovarian Cancer Market Insights report includes a comprehensive understanding of current ...

Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...

A coffee morning to support people who have been diagnosed with ovarian cancer is being held this Saturday, October 11, at ...

Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...

Earlier this year at the American Society of Clinical Oncology (ASCO) Congress, pharmaphorum spoke with Redwood City, ...

The report, which analysed data from July 2018 to December 2021, found that 36% of all women cancer patients in Chandigarh ...

More than 1,000 people marched to raise funds to support breast and ovarian cancer patients through the Gouverneur Breast and ...

Europe's health regulator has recommended the approval of GSK's cancer treatment Zejula as a first option to keep advanced ovarian cancer at bay in women who have responded to chemotherapy, the ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Surgeons who previously shared patients with physicians who frequently performed opportunistic salpingectomy (OS) were more likely to adopt the procedure themselves, according to a study published in ...

Oncoinvent ASA, a clinical-stage radiopharmaceutical company developing innovative treatments for solid cancers, today announced positive final 24-month follow-up results from its Phase 1 clinical ...

Breast cancer was once a leading cause of death for Jewish women, but decades of research have led to a more than 90% ...